Hopefully we will get more than 2 bidding for LANI.
We don't want to be subservient to one bidder where they make the rules. We want to have better conditions compared to Relenza such as regular payments instead of once yearly, higher royalty and also good marketing for the product.
I would imagine the worst thing would be to have a vaccine maker selling it and for it to be a part of a suite of products in the antiviral market. We want an aggresive company who knows how to manufacture and then market the product for maximum sales and therefore this should mean maximum gain to us.
- Forums
- ASX - By Stock
- BTA
- are relenza sales biting into tami sales???
are relenza sales biting into tami sales???, page-18
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries